As a follow up to survey results released on March 11, 2020, April 14, 2020 and July 20, 2020, today Institute for Supply Management? (ISM?) released its fourth round of dedicated research on COVID-19 impacts on businesses and their supply chains.
Analysis of a poll conducted by Verdict to assess the impact of COVID-19 on the drug supply chain showed that 90% are either highly or partially concerned about the disruption.